Emerging trends in invasive Streptococcus dysgalactiae subsp. equisimilis infections in Denmark, 2014 to 2024: a nationwide genomic and registry-based study

BACKGROUND Increasing incidence rates of invasive Streptococcus dysgalactiae subspecies equisimilis (iSDSE) have been detected worldwide. AIM We aimed to investigate iSDSE infection incidence rates in Denmark during 2014–2024, and characterise the genomic population structure of a subset of iSDSE isolates and their antimicrobial resistance (AMR). METHODS Using national register data, we estimated overall and sex-/age-stratified iSDSE incidences during 2014–2024, by retrospectively identifying cases of invasive infections with group C and G streptococci or S. dysgalactiae (including specified as subspecies equisimilis ). From the voluntary national beta-haemolytic streptococci laboratory surveillance system, whole-genome-sequenced isolates from August 2020−September 2022 were used to investigate the iSDSE genomic population structure. Susceptibility to penicillin, erythromycin and clindamycin was determined and AMR genes identified. RESULTS During 2014–2024, iSDSE incidence rates increased significantly (linear trend analysis p emm -type stG62647 , a variant associated internationally with higher virulence, dominated. All isolates were phenotypically susceptible to penicillin but approximately 10% were respectively erythromycin and clindamycin resistant. High erythromycin resistance prevalence (57%; 39/68), coinciding with gene ermA , occurred in one genetic cluster. CONCLUSION The findings illustrate the need for national registry-based surveillance to detect epidemiological changes and potential outbreaks. Further, continuous genomic surveillance can monitor the occurrence and expansion of genetic clades and AMR genes.